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Genomic imprinting, growth and maternal–fetal interactions
Féaron C. Cassidy and Marika Charalambous*,‡
ABSTRACT
In the 1980s, mouse nuclear transplantation experiments revealed
that both male and female parental genomes are required for
successful development to term (McGrath and Solter, 1983; Surani
and Barton, 1983). This non-equivalence of parental genomes is
because imprinted genes are predominantly expressed from only one
parental chromosome. Uniparental inheritance of these genomic
regions causes paediatric growth disorders such as Beckwith–
Wiedemann and Silver–Russell syndromes (reviewed in Peters,
2014). More than 100 imprinted genes have now been discovered
and the functions of many of these genes have been assessed in
murine models. The first such genes described were the fetal growth
factor insulin-like growth factor 2 (Igf2) and its inhibitor Igf2 receptor
(Igf2r) (DeChiara et al., 1991; Lau et al., 1994; Wang et al., 1994).
Since then, it has emerged that most imprinted genes modulate fetal
growth and resource acquisition in a variety of ways. First, imprinted
genes are required for the development of a functional placenta, the
organ that mediates the exchange of nutrients between mother and
fetus. Second, these genes act in an embryo-autonomous manner to
affect the growth rate and organogenesis. Finally, imprinted genes
can signal the nutritional status between mother and fetus, and can
modulate levels of maternal care. Importantly, many imprinted genes
have been shown to affect postnatal growth and energy homeostasis.
Given that abnormal birthweight correlates with adverse adult
metabolic health, including obesity and cardiovascular disease, it is
crucial to understand how the modulation of this dosage-sensitive,
epigenetically regulated class of genes can contribute to fetal and
postnatal growth, with implications for lifelong health and disease.
KEY WORDS: Adipose tissue, Leptin, Pregnancy
Introduction: genomic imprinting
The process of genomic imprinting results in the monoallelic
expression of genes based on their parental origin. This is an
epigenetic process because copies of identical deoxyribonucleic
acid (DNA) sequence may be either expressed or silenced. This
haploid expression is usually present in all tissues where the gene is
expressed, although there are examples of tissue-specific
imprinting. Following the discovery of the first imprinted genes in
the 1990s, the work of multiple groups has established that the
differential expression of imprinted genes is mediated by cis-
regulatory regions where DNA is differentially methylated on
cytosine residues (reviewed in Ferguson-Smith, 2011). This
differential methylation at crucial sites (known as imprinting
control regions or ICRs) is acquired during germline development
and maintained during the epigenetic reprogramming of the early
embryo and in somatic cells. Imprinted genes are often clustered in
the genome, where neighbouring maternally and paternally
expressed genes are co-ordinately controlled by a single ICR. The
ICRs regulate monoallelic transcription by modulating further local
epigenetic states, such as promoter methylation, expression of long
non-coding ribonucleic acids (RNAs) and histone modifications
(Ferguson-Smith, 2011).
Our knowledge of imprinting in humans has been informed by a
number of paediatric growth disorders with over-lapping phenotypes
and diverse aetiology, but which all alter the dosage of imprinted
genes. Mutations or epimutations in an ICR, or a duplication of a
section of chromosome from one parent (uniparental disomy or
UPD), results in imprinted genes being either over-expressed or not
expressed. Because many imprinted regions contain both paternally
and maternally expressed genes, it is difficult to determine which
genes are causal for their respective syndromes; in some cases,
imprinting disorders are likely to be caused by polygenic gene dosage
disruption. A common feature of imprinting disorders is
developmental abnormality, resulting in altered growth and nutrient
acquisition in early life (Table 1) and, hence, they highlight the key
role of imprinted genes in these physiological processes.
Imprinting has been described across Therian mammals
(including marsupials but not monotremes) and conservation of
many imprinted genes [e.g. insulin-like growth factor 2 (IGF2) and
its inhibitor IGF2 receptor (IGF2R), paternally expressed gene 1/
mesodermally expressed transcript (PEG1/MEST) and insulin
(INS)] within this group implies that imprinting was present in a
common vertebrate ancestor that exhibited viviparity and had a
placenta (Graves and Renfree, 2013). Coincident with their
taxonomic correlation with the presence of a placenta, many
imprinted genes are expressed in that organ and play a crucial role in
the process of placentation. Moreover, genes involved in
placentation are more likely to be imprinted (Graves and Renfree,
2013). In mammals, the level of dependence on the placenta
correlates with both the known number of imprinted genes within
each group (Renfree et al., 2009) and the complexity of their
regulation (Graves and Renfree, 2013). The presence of parental-
sex-dependent haploid expression has also been described in
flowering plants, a subset of plants that utilise a nourishing external
organ in their reproductive strategy. The endosperm in flowering
plants provides nourishment from the parent’s energy stores, much
like the placenta; similar selection pressures are likely to have led to
the convergent evolution of imprinted genes in these distant groups
(Pires and Grossniklaus, 2014).
Imprinted genes control maternal resource allocation during
pregnancy and lactation
This selective pressure for the imprinting of a gene has acted almost
exclusively at the maternal–offspring interface, giving imprinted genes
a unique role in influencing maternal resource allocation. Maternal
resource allocation is dependent on both the conceptus and themother,
and the role of imprinted genes reflects this, with imprinted gene action
affecting both and involved in communication between the two.
Imprinted genes that act in the conceptus to modulate maternal energy
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supply can be further subdivided into those acting in the placenta and
those acting in the fetus.
Fetal resource acquisition via the placenta
The rate at which nutrients can be supplied to the developing fetus is
dependent upon the placenta. The primary substrate for fetal growth
is glucose. Maternal–fetal glucose transfer is mediated by multiple
factors, including the maternal–fetal blood glucose concentration
gradient, the rate of blood flow and the placental glucose transporter
density (Hay, 1991). Placental amino acid transport to the fetus from
the maternal circulation operates against a concentration gradient
and is an energy-dependent process requiring specialised
transporter proteins (Hay, 1991).
Imprinting has been most extensively studied in humans and mice.
These organisms share similar placental physiology: both use a
hemochorial placenta where the maternal blood travels through
sinusoidal spaces lined by trophoblast cells, rather than an
endothelium, allowing for more efficient nutrient transfer (reviewed
in Rai and Cross, 2014). The distinct populations of cells in the
placenta, the trophoblast and the extraembryonic mesoderm,
differentiate early in embryogenesis with the trophoblast cells
invading the maternal uterine decidua following fertilisation. In
mice, at mid-gestation the definitive placenta is formed by intercalation
of the extraembryonic mesoderm (which will form the embryonic
vasculature) with trophoblast cells that channel maternal blood flow
through the placenta. The portion of the placenta where maternal and
fetal circulation is closely opposed is known as the labyrinth in mice.
The trophoblast further differentiates into multiple cell types that have
both endocrine and energy-storage properties (Rai and Cross, 2014).
The action of imprinted genes on placental development and
nutrient transport capacity is well established and has been reviewed
extensively (Fowden et al., 2011; Monk, 2015). Most imprinted
genes are monoallelically expressed in the placenta, and have been
shown to control early developmental processes that establish the
organ [e.g. Peg10 (Ono et al., 2006)]. In addition, imprinted gene
products can modulate labyrinth size and the surface area for
exchange [Igf2 (Sibley et al., 2004) and Growth factor bound
protein 10 (Grb10; Charalambous et al., 2010)] as well as vascular
branching density [Aquaporin (Guo et al., 2016)]. Placental
imprinted genes can also directly influence maternal physiology
by controlling the differentiation of the trophoblast-derived
endocrine cells (reviewed in John, 2017).
Imprinted genes involved in fetal resource acquisition
Nutrient uptake from maternal tissues and fetal growth rates are
interconnected processes (Hay, 1991). Imprinted genes can act
directly on fetal growth-promoting pathways and, thus, increase the
demand for maternal resources. The IGF pathway is a major fetal
growth-promoting pathway and includes two key components
encoded by imprinted genes (Igf2 and Igf2r; DeChiara et al., 1991;
Lau et al., 1994; Wang et al., 1994). Fetal growth is also restrained
by imprinted genes, including the Cyclin-dependent kinase
inhibitor 1C [Cdkn1c (Tunster et al., 2011)] and Grb10
(Charalambous et al., 2003). Grb10 encodes an adapter protein
that acts downstream of tyrosine-kinase receptors to inhibit
signalling, and is a crucial auto-regulatory component of the
nutrient-sensing mechanistic target of rapamycin (mTOR) pathway
(Hsu et al., 2011; Yu et al., 2011). Grb10 may act in the same
signalling pathway as the fetal growth promoter Delta-like
homologue 1 (Dlk1; Madon-Simon et al., 2014). Dlk1 is a
paternally expressed gene encoding a single-pass transmembrane
protein that can be cleaved to produce a soluble form that circulates
in the blood (Smas et al., 1997). Dlk1 expression levels in the
embryo are positively correlated to embryonic mass in the second
half of gestation (Cleaton et al., 2016). Dlk1 deletion causes growth
retardation (Cleaton et al., 2016; Moon et al., 2002) and
overexpression causes overgrowth independently of the placenta
(da Rocha et al., 2009). The signalling pathway bywhich DLK1 acts
has yet to be elucidated. However, DLK1 from the fetus is secreted
into the maternal circulation and acts to modify the pregnancy-
specific response to nutrient restriction (Cleaton et al., 2016).
In summary, imprinted genes in the conceptus produce products
that alter maternal resource allocation by: (i) altering the transport
capacity of the placenta; (ii) increasing fetal demand for resources
by their action on the intrinsic growth rate; and (iii) signalling to the
mother by the production of fetal/placental hormones that modify
maternal metabolism.
Energy homeostasis and resource allocation during pregnancy
The energetic cost of pregnancy is distributed amongst three
compartments, i.e. the energy invested in the products of
conception, the energy deposited as adipose tissue in the mother
and the energy required to maintain these new tissues (Thomson and
Hytten, 1961). Well-nourished humans and rodents accumulate
adipose tissue reserves during pregnancy in the first half of gestation
(Herrera and Ortega-Senovilla, 2014; King, 2000). The total cost of
pregnancy is correlated with pre-pregnancy fatness – individuals
with a higher body mass index (BMI) gain more weight during
pregnancy, both the adipose tissue reserve and conceptus mass
(Prentice and Goldberg, 2000). This suggests that adipose reserves
in the mother can produce a signal to the body that directs the level
of nutritional allocation after conception (Prentice and Goldberg,
2000). Leptin and other adipokines are ideal candidates for such
signalling molecules.
Table 1. Summary of human imprinting disorders
Disorder Phenotype Reference
Silver–Russell syndrome (SRS, OMIM
180860)
Small for gestational age at birth, distinctive features, including a triangular-shaped face and
macrocephaly, body asymmetry
Netchine et al.,
2012
Beckwith–Wiedemann syndrome
(BWS, OMIM 130650)
Large for gestational age with neonatal hypoglycaemia, overgrowth; macroglossia, often have
asymmetrical growth and embryonic tumours
Netchine et al.,
2012
Angelman syndrome (AS, OMIM
105830)
Microcephaly, a number of neurological disorders, including intellectual and speech
deficiencies, behavioural and sleep abnormalities and epilepsy
Buiting et al., 2016
Prader–Willi syndrome (PWS, OMIM
176270)
Hypotonia and feeding difficulties at birth followed by hyperphagia and obesity in childhood
and adulthood
Holm et al., 1993
Temple syndrome (TS, OMIM 616222) Small for gestational age at birth, with postnatal failure to thrive and hypotonia, followed by
reduced growth, early puberty and childhood truncal obesity
Ioannides et al.,
2014
Transient neonatal diabetes type 1
(TNDM, OMIM 601410)
Small for gestational age at birth, failure to thrive in the first few postnatal weeks,
hyperglycaemia and dehydration
Mackay and
Temple, 2010
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Leptin, a cytokine secreted exclusively by adipose tissue in
proportion to adipose mass, is a major determinant involved in
signalling the status of the energy reserve to central pathways
controlling appetite, energy expenditure and reproductive behaviour
(van Swieten et al., 2014). The action of leptin on the hypothalamic
control of energy homeostasis is complex, and a detailed description
is beyond the scope of this Review. Briefly, leptin signals to its
receptors expressed on the surface of first-order neurons in the
arcuate nucleus of the hypothalamus (ARH). Two populations of
neurons in the ARH have been well defined – the orexigenic
neuropeptide Y (NPY)/Agouti-related peptide (AGRP) neurons,
which are inhibited by leptin, and the anorexigenic pro-
opiomelanocortin (POMC) neurons, which are activated by leptin
(reviewed in van Swieten et al., 2014). These neurons project to
secondary hypothalamic sites, such as the paraventricular nucleus
(PVN), which controls feeding behaviour, and the dorsomedial
hypothalamus (DMH), which regulates the level of sympathetic
neuronal activity. A crucial intermediate signalling molecule is the
neuropeptide α-melanocyte-stimulating hormone (αMSH), which is
secreted by POMC neurons and acts on melanocortin receptors to
mediate downstream actions of leptin (van Swieten et al., 2014).
AGRP antagonises αMSH. Simply, a high leptin level from
adequate adipose stores suppresses appetite by deactivating
orexigenic neuronal pathways, and increases energy expenditure
by increasing activity and sympathetic neuronal activity. Increased
sympathetic neuronal activity in turn increases body temperature by
activating the expression of thermogenic genes in brown and beige
adipose tissue (van Swieten et al., 2014). Low stores of adipose
result in an opposite series of responses. Taken together, these
mechanisms maintain a homeostatic ‘set point’ that maintains body
weight within a narrow range.
Genetic and environmental modulations of leptin signalling
pathway components can cause alterations to the value of these set
points, or cause a failure to achieve homeostasis. For example, the
pups of mice exposed to a high-fat maternal diet during the perinatal
period fail to establish neuronal connectivity between the ARH and
PVN, resulting in altered body composition and a predisposition to
metabolic disease as adults (Vogt et al., 2014). Leptin-deficient
(ob/ob) mice and people with mutations in components of the
central melanocortin pathway are hyperphagic and obese –
maintaining a higher body weight set point owing to leptin
deficiency or resistance (reviewed by Farooqi and O’Rahilly, 2014).
Elegant studies utilising timed leptin-replacement therapy in
ob/obmice have demonstrated that this adipokine has a broad role in
reproduction (Malik et al., 2001). Leptin signalling is required for
fertility [by controlling gonadotrophin release (Padilla et al., 2017)],
conception and implantation. Moreover, leptin is required during
the perinatal period for lactation and for appropriate maternal
behaviours following parturition (Malik et al., 2001).
Pregnancy is associated with leptin resistance. Circulating levels
of leptin rise in the maternal blood in the second half of pregnancy;
however, the expression of orexigenic peptides NPY and AGRP in
the ARH remain stable. Moreover, injecting pregnant rats with
leptin does not suppress food intake or activate downstream αMSH
pathways (Ladyman et al., 2010). The leptin resistance of late
pregnancy is thought to be mediated by placental secretion of
hormones, specifically the prolactin and placental lactogen family
of molecules. Intracerebroventricular injection of prolactin into
female rats mimics the leptin resistance of pregnancy, and prolactin
receptor expression is widespread in the hypothalamic areas
associated with energy homeostasis (Ladyman et al., 2010).
Consistently, global deletion of the prolactin receptor in mice
causes changes to glucose homeostasis during pregnancy; however,
the contribution of leptin signalling to this phenotype has yet to be
explicitly tested (Rawn et al., 2015). Therefore, interactions between
placental hormone secretion and central leptin sensitivity are crucial
for an appropriate maternal response to pregnancy.
A second adipokine, adiponectin, has important functions during
pregnancy. Adiponectin is secreted from adipocytes according to
their size and acts on multiple tissues, predominantly to increase
insulin sensitivity (Stern et al., 2016). Adiponectin levels drop in
both rodent and human pregnancy and remain low during lactation
(Combs et al., 2003; Howell and Powell, 2017). Low adiponectin
levels during the second half of gestation are thought to increase
maternal insulin resistance, thus reducing maternal glucose uptake
and increasing the maternal–fetal glucose concentration gradient in
favour of fetal uptake. Consistent with this, obese pregnant women
and rodents who are insulin resistant give birth to large babies and
have further reduced adiponectin levels (Howell and Powell, 2017).
Furthermore, supplementing obese mice with adiponectin during
pregnancy can reverse both maternal insulin resistance and fetal
overgrowth (Aye et al., 2015).
Experiments utilising deletion and overexpression models in
mice have demonstrated that imprinted genes have important roles
in energy homeostasis – resulting in altered steady-state levels of
adiposity, adipokine production and sensitivity. However, many of
these phenotypic alterations have not yet been tested directly for
their contributions to the outcome of pregnancy, and adipokine
levels during pregnancy have been measured for only very few
imprinted gene manipulations (available data for murine models
published to date are summarised in Table 2).
The actions of imprinted genes in energy homeostasis can be
partitioned into those that modulate the central pathways, and those
that act in peripheral tissues to alter adipose mass and type (Fig. 1).
Imprinted genes mediating the central control of energy homeostasis
Gnas locus
The Gnas locus encodes maternally and paternally expressed
products (Gsα and XLαs), as well as several regulatory RNAs
(reviewed in Peters, 2014). Although Gsα is widely and
predominantly biallelically expressed, it is imprinted in only a
small number of tissues, including the kidney and neuroendocrine
tissues, where it is maternally expressed. Gsα encodes the stimulatory
G-protein alpha subunit that couples receptor-mediated signalling to
intracellular cyclic adenosine monophosphate – causing the
activation of protein kinase A (PKA). A second isoform from the
Gnas locus encodes XLαs, containing a distinct amino-terminal of
the protein from Gsα. This isoform is exclusively expressed from the
paternally inherited chromosome, predominantly in the brain and
endocrine tissues (reviewed by Peters, 2014).
Maternally inherited Gsα mutations cause
pseudohypoparathyroidism type A, a syndrome of multiple hormone
resistance, reduced sympathetic tone, early severe obesity and insulin
resistance (reviewed in Weinstein, 2014). This is phenocopied in mice
that inherit a deletion in the first exon of Gnas from their mother.
Central melanocortin signalling limits food intake and stimulates
sympathetic tone and energy expenditure, and the melanocortin
receptor 4 (MC4R) is known to couple to Gsα (Weinstein, 2014).
Maternally expressed Gsα is required for melanocortin signalling in the
DMH. Deletion of Gsα in this tissue causes obesity and insulin
resistance by reducing energy expenditure, both by reducing physical
activity and the expression of uncoupling protein 1 (UCP1) in brown
adipose tissue (BAT). Food intake is not affected. The mice were
resistant to the effect of melanocortin agonists, and these phenotypes
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Table 2. Murine models of imprinted gene regulation with details of energy homeostasis and maternal reproductive phenotypes and adipokine
levels
Gene Model Energy homeostasis phenotype
Phenotype of mutant
mothers Adipokine levels
Expressed
allele References
Gnas Global maternal deletion
of Gnas exon 1 –
specific to Gsα
Increased adipose deposition, reduced
glucose tolerance and insulin
sensitivity. Metabolic rate reduced
owing to reduced SNS activity
NR Leptin high
Adiponectin
unchanged
Maternal Chen, 2005
DMH deletion of Gnas
exon 1
Increased adipose deposition, reduced
glucose tolerance and insulin
sensitivity. Reduced energy
expenditure owing to reduced activity.
Food intake unchanged
NR Leptin high Chen et al., 2017
GnasXL Global deletion of Gnasxl
exon 1 – specific to
XLαs
Reduced adiposity, increasedmetabolic
rate, increased glucose tolerance and
insulin sensitivity. Increased SNS
activity
NR Leptin low
Adiponectin low
Paternal Xie et al., 2006
Peg1/
Mest
Deletion Reduced adipose stores Poor maternal care NR Paternal Nikonova et al., 2008
Transgenic over
expression in
mesenchymal cells
(aP2 promoter)
Increased adipocyte size NR Leptin
messenger RNA
expression
increased
Takahashi et al., 2005
Peg3 Deletion Increased body fat, reduced lean
mass. Reduced food intake and
body temperature. Central leptin
resistance
Poor maternal care
Reduced
maternal
investment in
pregnancy
Leptin high Paternal Curley et al., 2005
Asb4 Overexpression in
hypothalamic POMC
neurons
Reduced body fat, increased food
intake, increased energy
expenditure by thermogenesis and
activity
NR Leptin low Maternal Li et al. 2010
Snord116 Global deletion In mature animals, reduced body fat,
increased food intake, increased
energy expenditure by activity
NR NR Paternal Ding et al., 2008
Conditional deletion in
NPY neurons
In mature animals, reduced body fat,
increased food intake, increased
energy expenditure by activity
NR NR Paternal Qi et al., 2016
Magel 2 Global deletion Maturity-onset insensitivity to leptin
causes increased adipose mass and
reduced energy expenditure
NR Leptin high Paternal Bischof et al., 2007;
Mercer et al., 2013;
Pravdivyi et al., 2015
Necdin Global deletion Increased adipose mass on HFD
Food intake unchanged
NR NR Paternal Fujiwara, 2012
Cdkn1c Tissue-appropriate
overexpression (BAC
transgenic)
Reduced white adipose mass,
increased BAT activity
Food intake reduced
NR NR Maternal Van De Pette, 2016
Grb10 Global deletion of
somatic expression
(maternal transmission
of deletion)
Reduced white adipose mass,
increased lean mass, improved
glucose tolerance and insulin
sensitivity
Food intake unchanged
Reduced resource
allocation to litter
Leptin low Maternal Smith et al., 2007;
Cowley et al., 2014
Deletion in adipocytes
(adiponectin promoter-
Cre)
Increased WAT mass, impaired glucose
and insulin sensitivity. Thermogenic
gene expression is reduced in BAT,
and animals do not ‘brown’ their WAT
on cold challenge and have impaired
ability to defend BT
NR NR Liu et al., 2014
Dlk1 Global deletion Increased WAT mass, impaired glucose
and insulin sensitivity
Food intake unchanged
Increased maternal
allocation to litter
Leptin high Paternal Moon et al., 2002;
Cleaton et al., 2016
Tissue-appropriate
overexpression (BAC
transgenic)
Reduced WAT mass, improved
glucose tolerance and insulin
sensitivity
Food intake unchanged
NR Leptin low
Adiponectin
unchanged
Charalambous, 2012
Abbreviations: BAC, bacterial artificial chromosome; BAT, brown adipose tissue; BT, body temperature; DMH, dorsomedial hypothalamus; HFD, high-fat diet; mRNA,
messenger ribonucleic acid; NPY, neuropeptide Y; NR, not reported; POMC, pro-opiomelanocortin; SNS, sympathetic nervous system; WAT, white adipose tissue.
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were recapitulated when the MC4R was ablated in the DMH,
suggesting that they are a direct result of aberrant signalling through
this pathway. Surprisingly, cold tolerance was not affected in either the
Gsα or MC4R mutant mice, and both were able to mount a
transcriptional response to cold challenge in both BAT and by
promoting browning of white adipose tissue (WAT) (Chen et al., 2017).
Loss of XLαs causes a metabolic phenotype that is opposite to
that caused by maternal Gsαmutations – a reduced adiposity and an
increased metabolic rate owing to increased sympathetic nervous
system activity (Xie et al., 2006).
Peg3
Paternally expressed gene 3 (Peg3), which encodes a zinc-finger
protein is expressed in the placenta and ovaries as well as in some
neuroendocrine tissues (Hiby et al., 2001; Kuroiwa et al., 1996;
Relaix et al., 1996). Mice that inherit a Peg3 deletion from their
father are growth retarded at birth and remain small throughout
life. After weaning, males show delayed adipose accumulation and
females enter puberty late. In adulthood, the animals have
increased white adipose deposition and very high levels of
circulating leptin. The animals show reduced energy expenditure,
reduced resting body temperature and are less able to defend body
temperature following cold challenge (Curley et al., 2005). PEG3
is expressed in the developing hypothalamus (Li et al., 1999). In
young mice with deleted Peg3, the transcriptional regulation of
neuropeptides in the feeding centres of the hypothalamus is
disrupted. Although this is resolved in adulthood, the animals
remain less sensitive to leptin challenge, suggesting a permanent
change in the set points of central energy homeostasis (Curley
et al., 2005).
Females with an ablated Peg3 gene are poor mothers (Li et al.,
1999). During pregnancy, Peg3mutant mothers fail to increase food
intake in early gestation and, consequently, have a reduced post-
partum adipose reserve. In addition, wild-type pups born to Peg3
mutant mothers do not gain weight appropriately and enter puberty
late. Mutant mothers fail to express maternal-specific behaviours
such as pup-retrieval and nest building, and litters from such
mothers are much less likely to survive to weaning (Curley et al.,
2004; Li et al., 1999).
Interestingly, the consequences of either the mother or offspring
having a Peg3 mutation are strikingly similar, with pups having
reduced protection from the cold and reduced growth pre- and
postnatally. Despite the functional similarity, Peg3 is expressed
primarily in the paraventricular nucleus of the hypothalamus in the
adult, an area known to regulate maternal behaviours and milk let-
down, whereas the dysfunction due to mutation in the pups is most
likely to be because of the actions of Peg3 in the placenta. As noted
earlier, the placenta regulates maternal metabolic adaptation and
maternal behaviours through endocrine signalling, and the loss of
Peg3 in the offspring is associated with the altered expression of
prolactin-like genes (Broad and Keverne, 2011; John, 2013). The
placenta and hypothalamus may interact through endocrine
signalling, leading to a cumulative effect seen when both mother
and offspring lack Peg3 (Curley et al., 2004).
Asb4
Ankyrin repeat, SOCS box-containing 4 (Asb4) is a ubiquitin ligase
that is maternally expressed in mice but not imprinted in humans. It
is expressed in the first-order POMC and NPY/AGRP neurons of
the hypothalamus and its transcription is regulated by fasting, leptin
and insulin injection. Overexpression of Asb4 in POMC neurons
causes a hypermetabolic phenotype with increased energy
expenditure, reduced adipose mass and resistance to weight gain
on a high-fat diet. Therefore, ASB4 dosage mediates the sensitivity
of POMC neurons to leptin given that increased gene dosage
promotes leptin signalling (Li et al., 2010). In mice, Asb4 also plays
a role in the early vascular differentiation of the placenta (Townley-
Tilson et al., 2014).
Prader–Willi syndrome cluster
Snord116 maps to the critical region for Prader–Willi syndrome
(PWS) (characterised by early hypertonia and a failure to thrive
followed by hyperphagia at 2–3 years and obesity). It encodes a C/D
box small nucleolar RNA (SnoRNA). This family of catalytic
RNAs regulate RNA processing; however, the targets of Snord116
are unknown. In the mouse, Snord116 is exclusively expressed in
the brain, and localised to the appetite centres (Cavaille et al., 2000).
Deletion of Snord116 in mice causes postnatal growth retardation
NPY/
AGRP
POMC
DMH
PVN
Increased sympathetic
neuronal activity
Increased locomotor
activity 
Increased appetite
Endocrine function
Leptin
ARH
Gsα
XLαs
PEG3
PEG3
ASB4
SNORD116
MAGEL2
WAT
Energy storage
BAT
Thermogenesis
PEG1/MEST
CDKN1C
GRB10
DLK1
NECDIN
Fig. 1. Summary of the action of imprinted gene products on energy
homeostasis pathways. Imprinted genes act on the secretion of adipokines
by altering the balance of thermogenic brown adipose tissue (BAT) to white
adipose tissue (WAT). Imprinted genes may act on additional pathways to
modify body composition – for brevity these mechanisms are omitted from this
Review. In the hypothalamus, imprinted gene products are expressed in the
first order orexigenic (neuropeptide Y/Agouti-related peptide, NPY/AGRP) and
anorexigenic (pro-opiomelanocortin, POMC) arcuate nucleus (arcuate
nucleus of the hypothalamus, ARH) neurons and modulate their sensitivity to
leptin. These neurons interact with other hypothalamic structures such as the
dorsomedial hypothalamus (DMH) and paraventricular nucleus (PVN) to
mediate the physiological responses to leptin, such as suppression of appetite
and increased energy expenditure. Gene products that promote leptin
production or the activity of leptin signalling are shown in orange, those that
suppress leptin production or its actions are shown in green. References are
listed in Table 2. Abbreviations: ASB4, Ankyrin repeat, SOCS box-containing
4; CDKN1C, cyclin-dependent kinase inhibitor 1C; DLK1, Delta-like
homologue 1; GRB10, growth factor bound protein 10; PEG1/MEST, paternally
expressed gene 1/mesodermally expressed transcript.
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with an age-dependent effect on appetite. In early life, appetite is
reduced; however, later food intake is increased. The mice do not
become obese, rather they increase energy expenditure and maintain
a steady state of reduced adipose stores with respect to wild-type
littermates (Ding et al., 2008). Deletion of Snord116 in NPY/AGRP
neurons recapitulates all the phenotypes of the global deletion,
suggesting that Snord116 acts to alter the sensitivity of orexigenic
neurons to stimulus (Qi et al., 2016).
Magel2 encodes an E3 ubiquitin ligase expressed in the brain. It
is localised to the PWS locus in humans and the syntenic region in
mice, and is paternally expressed (Boccaccio et al., 1999). Deletion
of Magel2 from the paternally inherited allele in mice phenocopies
some aspects of PWS: the animals fail to thrive in the early postnatal
period, but later experience catch-up growth and as adults have
increased adiposity (Bischof et al., 2007). However, this energy
imbalance is not caused by hyperphagia in the mutant mice because
although they eat less, they have reduced energy expenditure.
Magel2 deletion causes multiple defects in hypothalamic function,
including the insensitivity of first order POMC neurons to leptin
(Mercer et al., 2013). Leptin insensitivity in Magel2 knock-out
animals is associated with an impairment in the developmental
accumulation of neuronal connections between arcuate nucleus
neurons and their targets, which occurs in the early postnatal period
(Maillard et al., 2016; Pravdivyi et al., 2015).
Imprinted gene actions in peripheral tissues
Peg1/Mest
Peg1/Mest is paternally expressed and encodes a member of the α/β-
hydrolase fold family (Kaneko-Ishino et al., 1995). When inbred
C57BL6 mice are fed a high-fat diet they show a variable adipose
tissue gain response. Peg1/Mestmessenger RNA levels are induced
in WAT following only 2 days of high-fat feeding, and expression
positively correlates with weight gain (Koza et al., 2006). Peg1/
Mest levels have been shown to correlate with adipocyte size in a
variety of genetic and dietary models of obesity (Nikonova et al.,
2008; Takahashi et al., 2005), and overexpression of Peg1/Mest in
adipocytes causes increased cell size. Mice with deleted Peg1/Mest
have reduced adipose stores and reduced adipokine production. It
has been proposed that Peg1/Mest induction during positive energy
balance controls the initial phase of adipose tissue expansion by
adipocyte hypertrophy (Nikonova et al., 2008).
Peg1/Mest mutant mothers exhibit abnormal maternal behaviour
– they fail to clean new-born pups and ingest extraembryonic
tissues, they do not retrieve pups to the nest, and perform poorly at
nest building. Consequently, pup survival is severely compromised
(Lefebvre et al., 1998).
Necdin
Necdin function in multiple contexts has been associated with the
restriction of cell proliferation, at least in part through interactions
with p53 (Hasegawa and Yoshikawa, 2008). Necdin is paternally
expressed in mice and humans, where it was mapped to the PWS
cluster (Chibuk et al., 2001). Deletion of Necdin in mice causes
hyperproliferation of the WAT compartment without affecting
central energy balance (Fujiwara, 2012). In mutant mice, the WAT
depot size increased without a concurrent increase in fat cell size,
indicating that expansion occurred by a mechanism of preadipocyte
hyperplasia (Fujiwara, 2012).
Cdkn1c
Increasing Cdkn1c expression in tissues where it is normally
expressed results in a phenotype similar to Silver–Russell
syndrome, pre- and postnatal growth retardation with failure to
gain adipose mass. Cdkn1c is expressed in multiple adipose tissue
depots in early perinatal life, and the level of expression reflects the
propensity of that depot to ‘brown’ – i.e. to express thermogenic
genes following stimulus. Mice with an increased Cdkn1c dosage
showed increased thermogenic gene activity in WAT and BAT and
increased body temperature. Deletion of Cdkn1c results in perinatal
lethality and, therefore, the postnatal phenotype could not be
assessed. However, ablation of Cdkn1c causes impaired BAT
development during embryogenesis (Van De Pette, 2016).
Grb10
Unusually for an imprinted gene, Grb10 is both maternally and
paternally expressed, but in different tissues. Maternal expression is
seen in the peripheral tissues whereas expression in the central
nervous system is solely paternal, with maternally expressed Grb10
controlling growth and energy homeostasis, and paternal Grb10
regulating social dominance behaviours (Garfield et al., 2011).
Postnatally, maternally inherited deletion of Grb10 results in
increased lean mass, reduced adipose mass (with low leptin) and
improved glucose homeostasis (Smith et al., 2007). Food intake is
not grossly affected. Grb10 expression is low in mature fat, but can
be induced in brown adipocytes by cold or adrenergic stimulation
(Liu et al., 2014). The deletion of Grb10 in mature fat cells causes
the failure of BAT to respond to stimuli and, consequently,
thermogenesis is impaired (Liu et al., 2014).
Cross-fostering studies have been used to disentangle the effects
of Grb10 loss in either the mother or the offspring on offspring
growth. These studies showed that Grb10 plays complementary
roles in the offspring and the mother. Wild-type pups cross-fostered
onto Grb10-deleted mothers (inheriting a deleted allele from their
mother) show reduced growth in early life compared with those
reared by wild-type mothers, suggesting that the normal role for
Grb10 in the mother is to increase resource allocation to the
offspring (Cowley et al., 2014). Interestingly, Grb10 mutant pups
fostered onto wild-type mothers gain more weight than wild-type
pups; however, this effect is negated if they are raised by mutant
mothers – indicating that the balance ofGrb10 dosage in the mother
and pup is a crucial determinant of nutrient flow from the mother to
her offspring (Cowley et al., 2014). Maternal care provision and
milk let-down were unaltered by Grb10 deletion, but in response to
increased demand and corresponding increased prolactin levels,
Grb10 mutant mothers could not increase milk production,
suggesting resistance to elevated prolactin. Grb10 is expressed in
the mammary epithelium during pregnancy; however, its role here is
unclear because no defect was found in the tissue morphology or the
constituents of the milk produced by Grb10 mutant females
(Cowley et al., 2014).
Dlk1
Dlk1 has been widely reported as an inhibitor of preadipocyte
differentiation because the soluble form of the protein can inhibit
in vitro differentiation of 3T3-L1 cells or mesenchymal cells into
adipocytes (Smas and Sul, 1997). Moreover, ectopic expression of
Dlk1 in adult WAT causes lipodystrophy (Lee et al., 2003).
However, lineage-appropriate overexpression of Dlk1 from a
bacterial artificial chromosome transgene (Dlk1-TG) does not
cause a failure of adipose expansion in adults, even when animals
are challenged with the hyperphagic leptin-deficient background
(Charalambous et al., 2014). Instead, Dlk1-TG mice have a larger
proportion of small adipocytes with increased insulin sensitivity
compared with wild-type mice. Conversely, Dlk1 null mice have
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larger adipocytes than wild-type mice (Moon et al., 2002).
Manipulation of Dlk1 dosage has the expected effect on
circulating leptin levels: Dlk1 null mice have elevated leptin and
Dlk1-TG have reduced levels. However, despite this, food intake is
not altered by either genetic manipulation (Charalambous et al.,
2014; Cleaton et al., 2016), suggesting impaired leptin sensitivity.
Dlk1 is likely to be acting during early life to increase adipocyte
number given that a lineage tracing study of cells expressing GFP
from a minimal Dlk1 promoter labelled adipose tissue in all depots
of the adult mouse. Moreover, ablation of this embryonic DLK1-
positive cell population caused a reduction in adipose depot size
(Hudak et al., 2014).
Dlk1 null mothers give birth to larger litters than wild-type
mothers (approximately one extra pup per litter), and overall litter
mass is increased. Moreover, the conceptus mass of like-genotype
offspring in litters from Dlk1 null mothers is not different from that
in litters from mothers with an intact Dlk1 gene. Therefore, Dlk1
null mothers increase their investment in each litter, rather than
reducing offspring size to offset offspring number. In addition,
although Dlk1 null mothers enter pregnancy with increased adipose
stores, they gain less adipose mass during pregnancy than wild-type
mothers. Altogether, females without a functional copy of Dlk1
invest more resources in pregnancy, suggesting that the normal role
for Dlk1 in female reproduction is to decrease nutrient allocation
(Cleaton et al., 2016).
Summary
Imprinted gene products act at multiple levels in the adipose–
hypothalamic axis to modulate set points of energy homeostasis.
Experiments frommurine models with ablation or overexpression of
imprinted genes demonstrate that they are required in the
hypothalamus to modulate the sensitivity of neuroendocrine
pathways to leptin. Moreover, the dosage of imprinted genes in
developing and mature adipose tissue can modulate leptin secretion
(summarised in Fig. 1).
The degree of maternal investment in pregnancy is positively
correlated with the pre-pregnancy adipose reserve. Mothers with
high BMI invest more in their own adipose reserves, and in the
products of conception (Prentice and Goldberg, 2000). Leptin has
been proposed as a potential mediator of this effect. Given that
imprinted gene products can modulate both leptin production and
central sensitivity to leptin, we predict that an impaired imprinted
gene dosage in females may influence their resource allocation as
mothers. To date, few imprinted genes have been tested explicitly
for their role in maternal physiology. However, where data exist, the
prediction that low leptin/leptin-resistant mothers should invest less
in a reproductive cycle appears consistent. Peg3, Peg1/Mest and
Grb10 deletions in the mother all reduce leptin signalling, and
maternal investment is reduced; conversely Dlk1 deletion increases
leptin production and maternal investment in pregnancy. Further
work is required to establish whether other models of imprinted
gene misregulation cause defects in the maternal phenotype, and if
other adipokines (such as adiponectin) are involved.
Conclusions
Since their discovery nearly 30 years ago, imprinted genes have
been a paradigm for exploring the epigenetic control of gene
expression. Moreover, their roles in early life growth and
placentation are undisputed. However, it is becoming increasingly
clear that imprinted gene function has a wider role in maternal
physiology during reproduction – both by modulating fetal and
placental endocrine products that signal to alter maternal energy
homeostasis, and by altering maternal energetic set points, thus
producing downstream actions on nutrient provisioning.
Uncovering the molecular nature of these pathways has a broad
application in terms of understanding natural reproductive strategies
and provides a basis for preventing complications to pregnancy in
human populations.
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